Targeting DLL4 in tumors shows preclinical activity but potentially significant toxicity.
Evaluation of: Yan M, Callahan CA, Beyer JC et al.: Chronic DLL4 blockade induces vascular neoplasms. Nature 463, E6-E7 (2010). Delta-like ligand 4 (DLL4) is a Notch ligand that is critical in the formation of a functional vascular network in tumors. Blockade of DLL4-mediated Notch signaling strikin...
Main Authors: | Li, J, Jubb, A, Harris, A |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
2010
|
Registos relacionados
-
Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
Por: Jubb, A, et al.
Publicado em: (2009) -
Dll4/Notch Signaling Pathway and Tumor Angiogenesis
Por: Xinyu DING, et al.
Publicado em: (2009-11-01) -
DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Por: Li, J, et al.
Publicado em: (2011) -
DLL4-Notch Signaling Mediates Tumor Resistance to Anti-VEGF Therapy In Vivo
Por: Li, J, et al.
Publicado em: (2011) -
Expression of DLL4 and VEGF in Lung Adenocarcinoma and their Relationship with Angiogenesis in Tumor
Por: Xiaoping LI, et al.
Publicado em: (2009-02-01)